x ULN

Related by string. X ULN * Xs . Xing . X. . XS . XD . xD . XING . xing . www.x . xs . Xer . XER . Xed . xd . xed . Xd . X : Mac OS X #.#.# [001] . X ray machines . X ray machine . chest X ray . Mac OS X . chest X rays . Native OS X . Mac OS X. . X Factor Cher Lloyd . x . X ray technician . X Men Origins . X ray Observatory . RELIANT VANTAGE X TRACT . Motorola Droid X . X Y . f x . GATE RELIANT VANTAGE X / : 3 X ULN . ULN . -normal ULN . normal ULN * *

Related by context. All words. (Click for frequent words.) 72 alanine aminotransferase ALT 72 alanine aminotransferase 71 aspartate aminotransferase 71 mL/min/#.# m 2 71 baseline serum creatinine 71 hypophosphatemia 70 SGPT 70 mmHg diastolic 70 confidence interval #.#-#.# 69 mmol l 69 mU liter 69 leucopenia 69 lopinavir r arm 69 transaminases 69 generalized edema 69 â ‰ ¥ 68 % Confidence Interval 68 CI -#.# 68 pg ml 68 PREZISTA r arm 68 normal ULN 68 -#.# mg dL [002] 68 ALT elevation 68 colorectal adenoma 68 mm Hg systolic 68 mIU L 68 aspartate aminotransferase AST 68 adjunctive placebo 68 mcg mL 68 serum aminotransferase levels 68 baseline HbA1c 67 ALT AST 67 transaminase elevations 67 urine albumin 67 #mg/dL [001] 67 laboratory abnormalities 67 prednisone prednisolone plus 67 mEq L 67 % CI #.#-#.# [001] 67 highest tertile 67 #.#mg/dL 67 HbA 1c 67 μmol L 67 serum ALT 67 pmol L 67 moderate renal impairment 67 hyperphenylalaninemia HPA due 67 oxycodone CR 67 Infusion Reactions Severe 67 glycated hemoglobin levels 66 neutropenia dehydration dyspnea 66 grade cervical intraepithelial 66 mU L 66 recurrent VTE 66 pyrexia mucositis sepsis febrile 66 log# copies mL 66 TAXUS p value 66 mm Hg diastolic 66 % CI #.#-#.# [004] 66 QTcF 66 leukopenia 66 aminotransferase levels 66 fasting triglyceride levels 66 intima media thickness 66 arterial thromboembolic events 66 REYATAZ r arm 66 mcg QD 66 elevated ALT 66 REMICADE monotherapy 66 infliximab monotherapy 66 nondiabetic patients 66 #mg/dL [002] 66 % CI #.#-#.# [007] 66 serum IGF 66 aminotransferases 66 CrCl 66 achieved ACR# 66 elevated creatinine 66 fluticasone salmeterol 66 HbA 1c levels 66 P = .# 66 severe exacerbations 66 sUA 66 g dl 66 macroalbuminuria 66 serum phosphate 66 μg mL 66 mcg BID 66 neutropenia thrombocytopenia 65 #mmHg [001] 65 ng dL 65 statistical significance p 65 serum potassium 65 TRAIL R1 65 elevated fasting glucose 65 hematologic toxicity 65 mmHg systolic 65 mg TID 65 hemoglobin A1c HbA1c 65 mild renal insufficiency 65 creatinine ratio 65 severe neutropenia 65 aminotransferase elevations greater 65 grade squamous intraepithelial 65 SGOT 65 lowest tertile 65 8mg/kg 65 morphometric vertebral fractures 65 nonfatal MI 65 hypercholesterolaemia 65 adjunctive ABILIFY 65 oral antidiabetic medication 65 transaminase 65 metabolic alkalosis 65 mucosal inflammation 65 coronary stenosis 65 pg mL 65 HOMA IR 65 CK MB 65 leukocyte count 65 4mg/kg 65 biochemical relapse 65 transferrin saturation 65 corticosteroid dose 65 cough dyspnea 65 mmol liter 65 dermatologic toxicities 65 lactate dehydrogenase LDH 65 #.#mmol L [002] 65 baseline A1C 65 Hb A1C 65 mIU ml 65 microgram kg 65 ULORIC 65 titrated glipizide 65 serum creatinine levels 65 glycosylated hemoglobin HbA1c 65 metastatic GIST 65 #ng/ml 65 fatigue asthenia 65 #mg/dl 65 FluCAM arm 65 confidence interval CI 64 μg ml 64 adverse reactions incidence 64 PRADAXA #mg 64 Erythropoietic therapies may 64 ischemia driven 64 binary restenosis 64 mild renal impairment 64 erosive gastritis 64 serum urate 64 % CI #.#-#.# [008] 64 total cholesterol triglycerides 64 elevated lipase 64 budesonide pMDI 64 unresectable HCC 64 overt nephropathy 64 hypokalemia 64 ug ml 64 severe renal impairment 64 % CI #.#-#.# [006] 64 ‰ ¥ 64 -#.# mg dL [001] 64 #.#/#.# mmHg [001] 64 fasting insulin 64 X ULN 64 baseline LDH 64 myalgia arthralgia 64 MADRS score 64 dizziness nausea diarrhea 64 elevated transaminases 64 PSA nadir 64 Left Ventricular Ejection Fraction 64 recurrent venous thromboembolism 64 SUVmax 64 Ishak fibrosis score 64 receiving Vectibix monotherapy 64 % AST SGOT 64 febrile neutropenia 64 prolonged QT interval 64 nmol l 64 triglyceride TG 64 ertapenem 64 umol L 64 creatinine clearance 64 paresthesias 64 uM 64 atorvastatin #mg 64 μg L 64 #mg BID [001] 64 PLX STROKE targeting 64 malignancy HCM 64 plasma triglycerides 64 #.#ng/ml 64 elevated serum creatinine 64 hypomagnesemia 64 NNT = 64 Hazard Ratio HR 64 onset diabetes mellitus 64 salmeterol fluticasone propionate 64 LDL triglycerides 64 placebo p = 64 certolizumab 63 QIDS SR 63 atazanavir ritonavir 63 advanced adenoma 63 log# IU mL 63 conjunctival hyperemia 63 rizatriptan 63 isoprostane 63 haematologic 63 nmol 63 serum uric acid 63 superficial edema 63 urinary cortisol 63 humanized interleukin 6 63 μg kg 63 histologic subtype 63 Mg Usa 63 anemia hemoglobin 63 hip BMD 63 P ≤ 63 serum phosphorous 63 symptomatic intracranial hemorrhage 63 mg BID dose 63 vitreous floaters 63 AST ALT 63 Fasting blood glucose 63 MIC# [001] 63 ALT flares 63 tolterodine ER 63 BENICAR HCT 63 fasting plasma glucose FPG 63 neutropaenia 63 mL/min/#.# m2 63 μg liter 63 creatine phosphokinase 63 cisplatin vinorelbine 63 mmHg p = 63 ARCOXIA 63 glycated hemoglobin 63 placebo p 63 hypercalcemia 63 non splenectomized 63 interleukin IL -6 63 IU ml 63 oxycodone IR 63 mg QD 63 -#.# ± [002] 63 sensory neuropathy 63 glycated hemoglobin HbA1c 63 apolipoprotein B 63 HBeAg seroconversion 63 peripheral sensory neuropathy 63 deep venous thromboses 63 AUC0 63 mean baseline HbA1c 63 μg dl 63 recurrent DVT 63 nmol L. 63 serum transaminases 63 angioneurotic edema 63 ATACAND 63 lispro 63 r2 = 63 elevated LDH 63 p = NS 63 mg kg Hematide 63 receiving XGEVA 63 tirofiban 63 CI #.#-#.# [001] 63 Mg Uk 63 ALT elevations 63 p = .# [002] 63 Skin sterol 63 Index CDAI 63 #.#g/day 63 triglycerides TG 63 asthenia 63 mg ustekinumab 63 mg p = 63 nonfatal myocardial infarction 63 VIIBRYD 63 SCr 63 serum triglycerides 63 ECOG PS 63 causality incidence 63 cerebrovascular events 63 TEAEs 63 Serum creatinine 63 advanced adenomas 63 receiving ISENTRESS 63 diastolic BP 63 nicardipine 63 asthenia fatigue 63 oral allopurinol 63 ug kg 63 ara C 63 abdominal pain flatulence 63 plus methotrexate 62 nmol liter 62 relapsed MM 62 adefovir treated 62 troponin T 62 urinary albumin excretion 62 comparator arm 62 hemodynamically significant 62 plus GP IIb 62 N telopeptide 62 pericardial effusion 62 headache abdominal pain 62 CRP marker 62 HbA1c levels 62 g trans fats 62 nasopharyngitis upper 62 carotid artery intima media 62 5-FU/LV 62 preoperative PSA 62 advanced hepatocellular carcinoma 62 pT3 62 ARB telmisartan 62 neutrophil counts 62 -#.# log# copies mL 62 plasma leptin 62 neuropathy sensory 62 cGy 62 thromboembolic complications 62 #.#-#.# [011] 62 serum phosphorus 62 desvenlafaxine succinate 62 QRS duration 62 genitourinary GU 62 hepatic enzymes 62 HGPIN 62 systemic corticosteroid 62 Acetate Rectal Suppositories 62 nadroparin 62 Scale EDSS score 62 diastolic blood pressures 62 linaclotide treated 62 mmol L. 62 nonfatal stroke 62 achieved statistical significance 62 See WARNINGS 62 μg d 62 diabetes mellitus DM 62 #.#/#.# mm Hg [003] 62 ejection fractions 62 Fasting glucose 62 mL sec 62 HER2 expression 62 % CI #.#-#.# [003] 62 stomatitis 62 serum estradiol 62 serum testosterone 62 mg kg dose 62 severe NCI CTC 62 CI #.#-#.# [002] 62 IIIa inhibitors 62 DAS# scores 62 Montgomery Åsberg Depression 62 per deciliter mg 62 progesterone receptor negative 62 autoantibody positive 62 antibody titer 62 triiodothyronine 62 Psoriasis Area 62 mCi 62 nonsignificant difference 62 mg dosed twice 62 irbesartan 62 benazepril 62 tipranavir r 62 NPH insulin 62 hydroxymethyl coenzyme 62 mmol L 62 LV ejection fraction 62 liver histology 62 -#.# ± [001] 62 #mg/day [002] 62 Expanded Disability Status 62 DAS# CRP 62 p = #.# [003] 62 CC genotype 62 ß = 62 serum sodium 62 HbA1C 62 Primary endpoints 62 micrograms mL 62 cervical intraepithelial neoplasia 62 Crohn Disease Activity 62 fasting plasma 62 HBeAg negative 62 biologic DMARD 62 elevated uric acid 62 tertile 62 mg qd 62 systemic embolism 62 % CI #.#-#.# [005] 62 urinary N telopeptide 62 mg/# hours 62 elevated LDL cholesterol 62 serum concentrations 62 latent celiac disease 62 CI = 62 somnolence headache 62 hydroxyvitamin D levels 62 Flu Cy 62 elevated IOP 62 ENL recurrence 62 permanently discontinue Vectibix 62 plus OBT 62 CR CRu 62 abacavir lamivudine 62 hyperhomocysteinemia 62 erythrocyte sedimentation rate 62 polyp recurrence 62 insomnia somnolence 62 mg/m2 dose 62 Severity Index PASI 62 lymphopenia 62 epistaxis 62 Severe hypoglycemia 62 headache nasopharyngitis 62 Xalatan R 62 Eur J Endocrinol 62 CIMZIA TM 61 included exfoliative dermatitis 61 serum calcium 61 mg BID 61 ACTEMRA TM 61 nondiabetics 61 pulmonary exacerbations 61 myocardial infarction ventricular fibrillation 61 intact parathyroid hormone 61 CIN2 + 61 FDG uptake 61 thrombocytopenia neutropenia 61 TT genotype 61 NovoLog ® Mix 61 nonfasting triglyceride levels 61 statin monotherapy 61 CIN3 61 HbA1C levels 61 PROCTOCORT ® Suppository Hydrocortisone 61 chlorambucil 61 IU mL 61 renal insufficiency 61 #mmHg [002] 61 peripheral edema 61 plasminogen activator inhibitor 61 mEq 61 SSRI citalopram 61 mg m² 61 dysuria 61 #mg/day [001] 61 metoprolol tartrate 61 NATRECOR R 61 liver enzymes ALT 61 tHcy 61 gastrointestinal perforation 61 #mm Hg 61 pmol liter 61 symptomatic VTE 61 μg dL 61 angiotensin converting enzyme inhibitors 61 reduce serum phosphate 61 nausea somnolence 61 albumin excretion rate 61 liver transaminases 61 statistically significant p 61 pCR 61 unfractionated heparin UFH 61 recurrent UTI 61 headache somnolence 61 lactate dehydrogenase 61 INCB# [003] 61 angiotensin converting enzyme inhibitor 61 plasma folate 61 bioavailable testosterone 61 #OHD 61 PaO 2 61 saline placebo 61 fluorouracil leucovorin 61 glycosylated hemoglobin levels 61 Triamcinolone 61 stage IIIb IV 61 rhinoconjunctivitis 61 salmeterol fluticasone 61 urinary oxalate 61 myelodysplastic myeloproliferative diseases 61 azathioprine monotherapy 61 Papillary 61 fractional shortening 61 serum homocysteine 61 IPSS 61 DAS# [002] 61 gastroduodenal 61 colorectal carcinoma 61 mcg linaclotide 61 primary hypercholesterolemia 61 mso footer margin 61 elevated hsCRP 61 myocardial infarction stroke 61 HDL LDL ratio 61 tertiles 61 cholesterol LDL C 61 Peginterferon Alfa 2a 61 nmol L 61 autoimmune thyroid 61 dapagliflozin plus 61 serum calcium levels 61 aplastic anemia AA 61 Hazard Ratio = 61 hematopoietic cancers 61 CDAI score 61 -#.# log# 61 abdominal distention 61 Stent thrombosis 61 aspirin clopidogrel 61 proctitis 61 interquartile range 61 NYHA functional class 61 metastatic malignant 61 lumbar spine BMD 61 ritonavir boosted 61 CTAP# 61 alanine transaminase 61 mg d 61 HBeAg negative patients 61 vitreous haze 61 BMS p = 61 ng ml 61 valsartan amlodipine 61 nasopharyngitis 61 DETROL LA 61 ng mL 61 chronic thromboembolic pulmonary 61 discontinuations due 61 alkaline phosphatase 61 hemoglobin A1c levels 61 prolactin levels 61 mg Proellex 61 hepatic enzyme 61 Pred Forte 61 systolic dysfunction 61 FOLFIRI alone 61 glomerular filtration 61 gemcitabine carboplatin 61 BYSTOLIC 61 MACCE 61 OGTT 61 pretest probability 61 LVEF 61 PSADT 61 neovascular 61 ug mL 61 eplerenone 61 transaminase levels 61 proteinuria 61 gadobutrol 61 thromboembolic events 61 MBq 61 #mg BID [003] 61 μmol l 61 thyrotropin 61 glulisine 61 pulmonary capillary wedge 61 ng dl 61 dermatologic reactions 61 ACE Inhibitors 61 BENICAR 61 Zometa hazard 60 ug dose 60 β blocker 60 NOLVADEX 60 #q# deletion syndrome 60 Interferon beta 1b 60 serum leptin 60 hypocalcemia 60 hypercalciuria 60 triacylglycerol concentrations 60 NMIBC 60 proximal DVT 60 concomitant medications 60 atrioventricular block 60 GH deficiency 60 hepatorenal syndrome 60 mcg kg 60 echocardiographic parameters 60 extrapyramidal symptoms 60 MCyR 60 HER2 amplification 60 metformin sulfonylureas 60 mg/#.# mg [001] 60 NYHA Class III 60 MULTAQ 60 serum sodium concentration 60 lymphocytosis 60 aminotransferase ALT 60 PAOD 60 EDSS score 60 hormone receptor negative 60 improves glycemic 60 serum CRP 60 heFH 60 International Prostate Symptom 60 Hazard Ratio 60 systolic blood pressures 60 D dimer 60 thyrotropin levels 60 mcg dL 60 metastatic carcinoid tumors 60 doxorubicin cyclophosphamide 60 nonobese 60 fluvoxamine Luvox 60 elevated triglyceride levels 60 DLTs 60 Peg IFN 60 left ventricular diastolic 60 thrombophlebitis 60 imiquimod cream 60 Adjuvant chemotherapy 60 fluticasone propionate FP 60 adriamycin 60 calculated creatinine clearance 60 metformin monotherapy 60 mg + GLY 60 XIENCE V PROMUS Stent 60 nonfatal myocardial infarction MI 60 hsCRP levels 60 creatine kinase CK 60 #OHD levels 60 venlafaxine XR 60 receiving PEGINTRON 60 ADCS CGIC 60 somatostatin analog 60 serum urate levels 60 episodic migraine 60 #-#,# mg 60 Stomatitis 60 acarbose 60 baseline Hb 60 fasting plasma glucose 60 hypervolemic hyponatremia 60 IIIa inhibitor 60 bronchial hyperresponsiveness 60 neutropenia anemia 60 sUA levels 60 rapid virologic response 60 hematologic adverse 60 idiopathic PAH 60 multivariable adjusted 60 microg 60 CK # plasma concentrations 60 metronidazole gel 60 E selectin 60 Lucentis monotherapy 60 detrusor 60 mcg kg REBETOL 60 purpura ITP 60 artery stenosis 60 atopic asthma 60 neurodevelopmental impairment 60 nasopharyngitis headache 60 serum cortisol 60 gastric pH 60 serologically active systemic lupus 60 pooled comparator 60 subclinical hypothyroidism 60 #mg #mg #mg [003] 60 iPTH 60 creatine kinase MB 60 Plasma concentrations 60 lipoprotein Lp 60 carotid stenosis 60 endometrial hyperplasia 60 hyperlipemia 60 alanine transaminase ALT 60 cTnI 60 ACR# response 60 plasma cortisol 60 isolated systolic hypertension 60 60 serum LDL cholesterol 60 receiving INTRON 60 TNF Tumor Necrosis Factor 60 timolol 60 hypopneas 60 clinically meaningful reductions 60 serum bilirubin 60 ANCA associated 60 = #.#-#.# 60 splenectomized 60 Hemoglobin A1c HbA1c 60 ALT normalization 60 Hb A1c 60 del 5q 60 CCyR 60 CVD mortality 60 serum ferritin 60 Basal Cell 60 endometrial thickness 60 urinary excretion 60 cell adhesion molecule 60 mg dL 60 serum TSH 60 #mg QD [002] 60 min -1 60 NYHA Class II 60 System IPSS 60 statistically significant p = 60 Folfox 60 HbA 1C 60 cardiovascular hospitalization 60 undetectable viral 60 TNF alpha IL 60 PASI scores 60 CLL SLL 60 hemoglobin Hb 60 beclomethasone dipropionate 60 histological subtype 60 gm dl 60 EDSS scores 60 plus prednisone prednisolone 60 nadolol 60 Proteinuria 60 normotensive 60 death reinfarction 60 recurrent genital herpes 60 + PH# 60 anterior uveitis 60 incidence ≥ 60 J Am Coll 60 serum triglyceride levels 60 intercellular adhesion molecule 60 fatigue nausea vomiting 60 zonisamide SR 60 tamsulosin 60 tolvaptan 60 #mg doses [002] 60 inflammatory biomarkers 60 tamoxifen Nolvadex ® 60 IFN α 60 mcg Albuferon 60 brand ciclesonide HFA 60 homocysteine concentrations 60 Non Alcoholic Steatohepatitis 60 pruritus rash 60 A1c levels 60 baseline PASI 60 moderately emetogenic 60 CTAP# Capsules 60 serum retinol 60 CIN2 60 fraction LVEF 60 BUPHENYL 60 receiving VICTRELIS 60 TAXUS Express Stent 60 Nephrol Dial Transplant 60 periprocedural 60 candesartan cilexetil 60 Severity MSCS score 60 biopsy Gleason 60 atherogenic dyslipidemia 60 bilirubin elevations 60 neutropenia febrile neutropenia 60 Adenomas 60 3mg/kg 60 CR nPR 60 CHD CVD 60 Cmax 60 SGRQ 60 Endothelial function 60 hepatocellular carcinomas 60 nonvertebral fractures 60 postop 60 pulmonary infiltrates 60 refractory NSCLC 60 oral levofloxacin 60 fasting glucose levels 60 dimeglumine 60 unstable angina pectoris 60 locoregional recurrence 60 KRAS mutations occur 60 tissue oxygenation 60 dehydroepiandrosterone sulfate 60 annualized relapse 60 Hypotension 60 ® lenalidomide 60 serum lipid levels 60 reinfarction 59 anaplastic astrocytomas 59 g dL 59 carotid IMT 59 excess blasts RAEB 59 non valvular atrial 59 ecchymosis 59 metformin sulphonylurea 59 CIMZIA ™ 59 Prognostic significance 59 apnea hypopnea index 59 neutrophil count 59 hypertrichosis occurred 59 Engerix B 59 beta blocker therapy 59 daunorubicin 59 tranylcypromine 59 #.#mmol L [001] 59 serum PTH 59 VELCADE melphalan 59 Tasigna prolongs 59 TOVIAZ 59 underwent surgical resection 59 systolic hypertension 59 hyperemia 59 rectal tenesmus 59 DOXIL 59 diabetes dyslipidemia 59 low dose Iluvien 59 dose atorvastatin 59 autoantibody levels 59 glucuronide 59 prior chemotherapy regimens 59 elevated alkaline phosphatase 59 flutamide 59 dexamethasone Decadron 59 stomatitis pharyngitis 59 biochemical recurrence 59 International Prognostic Scoring 59 tryptase 59 tumor xenograft models 59 Letairis ambrisentan 59 mg q#h 59 proliferative retinopathy 59 mcg albinterferon alfa 2b 59 enterocolitis 59 refractory ischemia 59 hyperlipidaemia 59 #mg/m# [001] 59 bone marrow reticulin deposition 59 CRp 59 Teriflunomide 59 metformin sulfonylurea 59 K ras mutations 59 BMI z 59 mg/m2/day 59 symptomatic DVT 59 hour bronchodilation 59 Retreatment 59 Cystatin C 59 ruboxistaurin 59 CLINICAL STUDIES 59 serum sodium levels 59 pimecrolimus cream 59 thyroglobulin 59 plasma uric acid 59 GERD symptom 59 Ejection Fraction 59 abdominal adiposity 59 odds ratios ORs 59 BPH benign prostatic 59 acneform rash 59 spinal cord compression 59 #.#mmHg 59 fatigue abdominal pain 59 Low density lipoprotein 59 affective psychosis 59 Y BOCS 59 Kinoid 59 Arch Intern Med 59 Relapsing Remitting Multiple Sclerosis 59 erythematosus 59 pruritis 59 ml kg 59 Type IIa 59 creatine kinase 59 deoxy 59 intraclass correlation coefficient 59 glutamyl 59 Suppository Hydrocortisone Acetate Rectal 59 intravesical therapy 59 tapentadol ER 59 albumin excretion 59 Postoperative complications 59 macrovascular events 59 TIMP 1 59 hyperkalemia 59 ventricular tachyarrhythmia 59 MMSE score 59 azilsartan medoxomil 59 FOLFOX4 alone 59 protein excretion 59 Score IPSS 59 PROCTOCORT R 59 stable angina pectoris 59 XIENCE V vs. 59 nonischemic 59 g dietary fiber 59 CIMZIA TM certolizumab pegol 59 Soyabean Ext Bulk 59 Visual Analogue Scale VAS 59 linoleic acid LA 59 ß blockers 59 Soriatane R acitretin capsules 59 malignant neoplasm 59 serum parathyroid hormone 59 Sustained virologic response 59 idraparinux 59 alemtuzumab treated 59 atrophic gastritis 59 IOP lowering 59 plus dexamethasone 59 Myelosuppression 59 ACR# ACR# 59 T2 lesion volume 59 pyrexia 59 STRIDE PD 59 HF hospitalization 59 rs# [004] 59 Response Evaluation Criteria 59 thyrotoxicosis 59 pharyngolaryngeal pain 59 hyperactivity impulsivity 59 urinary albumin 59 Brief Psychiatric 59 abnormal lipid 59 nM 59 urate lowering 59 μg g 59 log# reduction 59 blood phenylalanine Phe 59 Score TOS 59 R Saizen R 59 plus glycoprotein IIb 59 LymphoStat B belimumab 59 tacrolimus ointment 59 doxazosin 59 quetiapine risperidone 59 rFSH 59 definite stent thrombosis 59 achieved PASI 59 serum folate 59 rosuvastatin #mg 59 biphasic insulin aspart 59 Postoperatively 59 complement inhibitor eculizumab 59 g t PGE 59 atheroma volume 59 acromegalic patients 59 COMBIVIR 59 antiarrhythmic drug 59 COHb 59 density lipoprotein cholesterol HDL 59 FOLFOX6 59 detrusor overactivity 59 glycosylated hemoglobin 59 Pharmacokinetics PK 59 grams dietary fiber 59 LDL cholesterol HDL cholesterol 59 left ventricular systolic 59 FluCAM 59 rhinorrhea 59 thromboxane A2 59 μg doses 59 recurrent glioblastoma multiforme 59 non constipating irritable 59 warfarin sodium 59 oxyhemoglobin 59 VANOS TM fluocinonide Cream 59 piperacillin tazobactam 59 insulin detemir 59 TRAIL R2 59 HES CEL 59 BRCA1 mutation carriers 59 ezetimibe simvastatin 59 diarrhea dyspepsia 59 inhaled fluticasone 59 Peginterferon alfa 2b 59 mg tid 59 pegIFN 59 hypoglycemic events 59 Operative mortality 59 Ovitrelle R Serostim 59 PCWP 59 mol L 59 racemic albuterol 59 postoperative AF 59 ABC/3TC 59 corrected QT interval 59 Known hypersensitivity 59 confidence intervals CIs 59 ACR Pedi 59 colorectum 59 C1 INH deficiency 59 highly emetogenic 59 sitosterol 59 RLAI

Back to home page